Antiadhesion effects of docosahexaenoic acid on normal human peritoneal and adhesion fibroblasts

Fertility and Sterility

Volumn 88, Issue 6, 2007, Pages 1657-1662

  Victory, Rahi ^a   Saed, Ghassan M ^a   Diamond, Michael P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adhesion barriers; adhesions; DHA; Docosahexaenoic acid; inflammation; omega 3; peritoneum; transforming growth factor 1; type I collagen; vascular endothelial growth factor

Indexed keywords

ADHESIVE AGENT; COLLAGEN TYPE 1; DOCOSAHEXAENOIC ACID; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ARTICLE; CELL ADHESION; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; EXPERIMENTAL STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; LAPAROTOMY; PERITONEUM; PERITONEUM ADHESION; PERITONEUM CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; UNIVERSITY HOSPITAL;

ADHESIONS; CELL ADHESION; CELLS, CULTURED; COLLAGEN TYPE I; DOCOSAHEXAENOIC ACIDS; DRUG EVALUATION, PRECLINICAL; FIBROBLASTS; GENE EXPRESSION; HUMANS; PERITONEUM; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 36749092870     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.01.123     Document Type: Article

References (25)

1. Diamond M.P., and Freeman M.L. Clinical implications of post-surgical adhesions. Hum Reprod Update 7 (2001) 567-576
2. Cheong Y.C., Laird S.M., Li T.C., Shelton J.B., Ledger W.L., et al. Peritoneal healing and adhesion formation/reformation. Hum Reprod Update 7 (2001) 556-566
3. Ray N.F., Larsen Jr. J.W., Stillman R.J., and Jacobs R.J. Economic impact of hospitalizations for lower abdominal adhesioloysis in the United States in 1988. Surg Gynecol Obstet 176 (1988) 271-276
4. Kota B.P., Huang T.H., and Roufogalis B.D. An overview on biological mechanisms of PPARs. Pharmacol Res 51 (2005) 85-94
5. Saed G.M., and Diamond M.P. Molecular characterization of postoperative adhesions: the adhesion phenotype. J Am Assoc Gynecol Laparosc 11 (2004) 307-314
6. Saed G.M., Zhang W., and Diamond M.P. Molecular characterization of fibroblasts isolated from human peritoneum and adhesions. Fertil Steril 75 (2001) 763-768
7. Saed G.M., Zhang W., Chegini N., Holmdahl L., and Diamond M.P. Transforming growth factor beta isoforms production by human peritoneal mesothelial cells after exposure to hypoxia. Am J Reprod Immunol 43 (2000) 285-291
8. Zhao G., Etherton T.D., Martin K.R., Vanden Heuvel J.P., Gillies P.J., West S.G., et al. Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochem Biophysic Res Commun 336 (2005) 909-917
9. Li H., Ruan X.Z., Powis S.H., Fernando R., Mon W.Y., Wheeler D.C., et al. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int 67 (2005) 867-874
10. Yamamoto K., Itoh T., Abe D., Shimizu M., Kanda T., Koyama T., et al. Identification of putative metabolites of docosahexaenoic acid as potent PPAR gamma agonists and antidiabetic agents. Bioorg Med Chem Lett 15 (2005) 517-522
11. Mishra A., Chaudhary A., and Sethi S. Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPAR alpha-dependent pathway. Arterioscler Thromb Vasc Bio 24 (2004) 1621-1627
12. Horrocks L.A., and Young K.Y. Health benefits of docosahexaenoic acid (DHA). Pharmacol Res 40 (1999) 212-215
13. Saed G.M., and Diamond M.P. Apoptosis and proliferation of human peritoneal fibroblasts in response to hypoxia. Fertil Steril 78 (2002) 137-143
14. Saed G.M., and Diamond M.P. Hypoxia-induced irreversible up-regulation of type I collagen and transforming growth factor-beta1 in human peritoneal fibroblasts. Fertil Steril 78 (2002) 144-147
15. Munkarah A.R., Genhai Z., Morris R., Baker V.V., Deppe G., Diamond M.P., et al. Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells. Gynecol Oncol 88 (2003) 429-433
16. Munkarah A.R., Morris R., Baumann P., Deppe G., Malone J., Diamond M.P., et al. Effects of prostaglandin E2 on proliferation and apoptosis of epithelial ovarian cancer cells. J Soc Gynecol Invest 9 (2002) 168-173
17. Binda M.M., Molinas C.R., and Koninckx P.R. Reactive oxygen species and adhesion formation: clinical implications in adhesion prevention. Hum Reprod 18 (2003) 2503-2507
18. Israelian-Konaraki Z., and Reaven P.D. Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications. Cardiol Rev 13 (2005) 240-246
19. Grommes C., Landreth G.E., and Heneka M.T. Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists. Lancet Oncol 5 (2004) 419-429
20. Cuzzocrea S., Pisano B., Dugo L., Ianaro A., Maffia P., Patel N.S., et al. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation. Eur J Pharmacol 483 (2004) 79-93
21. Fruchart J.C., Duriez P., and Staels B. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr Opin Lipidol 10 (1999) 245-257
22. Mishra A., Chaudhary A., and Sethi S. Oxidized omega-3 fatty acids inhibit NF-κb activation via a PPAR-dependent pathway. Arterioscler Thromb Vasc Bio 24 (2004) 1621-1627
23. Al-Awadhi A.M., and Dunn C.D. Effects of fish-oil constituents and plasma lipids on fibrinolysis in vitro. Br J Biomed Sci 57 (2000) 273-280
24. Finnegan Y.E., Howarth D., Minihane A.M., Kew S., Miller G.J., Calder P.C., et al. Plant and marine derived (n-3) polyunsaturated fatty acids do not affect blood coagulation and fibrinolytic factors in moderately hyperlipidemic humans. J Nutr 133 (2003) 2210-2213
25. Woodman R.J., Mori T.A., Burke V., Puddey I.B., Barden A., Watts G.F., et al. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atheroscler 166 (2003) 85-93